KLA Corporation (KLAC) FY2025 10-K Annual Report

Filed: Aug 8, 2025
Health Care
Optical Instruments & LensesSEC EDGAR

KLA Corporation (KLAC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Aug 8, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

KLA Corporation FY2025 10-K Analysis

Business Overview

  • Core business model: Semiconductor process control and yield management solutions provider
  • Patent portfolio expanded to over 8,500 active patents and 3,500 pending applications as of June 30, 2025
+2 more insights

Management Discussion & Analysis

  • Revenue increased in fiscal 2025 driven by growth in services (22% of total revenue) and Taiwan semiconductor demand; revenue from Chinese customers decreased YoY
  • Gross margin and overall financial performance improved in fiscal 2025 compared to fiscal 2024 due to higher volume and cost management (exact % not provided)
+3 more insights

Risk Factors

  • Regulatory risk: Impact of more stringent U.S. export controls reducing revenue share from China, which declined from 43% to 33% of total revenues in fiscal 2025
  • Geopolitical risk: Significant revenue concentration in Asia, especially Taiwan (27% of total revenues in 2025), exposing firm to regional economic and political changes
+3 more insights

KLA Corporation FY2025 Key Financial Metrics
XBRL

Revenue

$12.2B

+23.9% YoY

Net Income

$4.1B

+47.1% YoY

Net Margin

33.4%

+526bp YoY

ROE

86.6%

+456bp YoY

Total Assets

$16.1B

+4.1% YoY

EPS (Diluted)

$30.37

+49.8% YoY

Operating Cash Flow

$4.1B

+23.4% YoY

Source: XBRL data from KLA Corporation FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.